Article(id=1330233671157658169, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.02.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1693756800000, receivedDateStr=2023-09-04, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795082021749, onlineDateStr=2026-11-19, pubDate=1707494400000, pubDateStr=2024-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795082021749, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795082021749, creator=13701087609, updateTime=1795082021749, updator=13701087609, issue=Issue{id=1330233670775976505, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='2', pageStart='165', pageEnd='308', issueExtLink='null', onlineDate='null', pubDate='1707494400000', pubDateStr='2024-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795082021659, creator='13701087609', updateTime=1795082707094, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236546143334510, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236546143334511, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=176, endPage=186, ext={EN=ArticleExt(id=1330233671333818938, articleId=1330233671157658169, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Formulation Design and Optimization of ADC, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Antibody-drug conjugates (ADC) combine the targeting ability of monoclonal antibodies and the potent cytotoxicity of small molecule substances, becoming a research focus in the current biopharmaceutical field. Although various ADCs have been marketed globally, challenges still exist in formulation and stability. This review outlines the key points and difficulties in ADC formulation development and clinical application from the perspectives of antibody, linker, and small molecule substance selection for ADC, and proposes a stability study plan during ADC use, aiming to provide references for the future ADC development.

, authors=Wenpeng ZHAO, authorsList=Wenpeng ZHAO, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233671530951227, articleId=1330233671157658169, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=ADC的制剂处方设计和优化, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

抗体偶联药物(antibody-drug conjugate,ADC)结合了单克隆抗体的靶向性和小分子物质的强大杀伤力,成为当前生物制药领域的研究焦点。虽然全球已有多种ADC上市,但在配方和稳定性方面仍存在挑战。该文从ADC的抗体、连接子和小分子物质选择的角度,概述了ADC配方开发和临床应用中的关键和难点,并提出了ADC使用期间的稳定性研究方案,旨在为未来ADC的开发提供参考。

, authors=赵文鹏, authorsList=赵文鹏, authorCompany=null, correspAuthors=null, authorNote=

赵文鹏(2003—),男,2021级本科生。E-mail:

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=vQ09CUdiDKC9r4PdUm8o6g==, magXml=rFfmiMuaTXjUG/M8s9tTWA==, pdfUrl=null, pdf=1847DT1EtK+OnA9xZEFcBg==, pdfFileSize=2036996, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=bKJP4NolK8PAvoBzKLtJOA==, mapNumber=null, fund=null)}, authors=[Author(id=1330233671790998080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=1192556601@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233671858106946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, authorId=1330233671790998080, language=EN, stringName=Wenpeng ZHAO, firstName=Wenpeng, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shenyang Pharmaceutical University, Shenyang 110016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233671929410115, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, authorId=1330233671790998080, language=CN, stringName=赵文鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=沈阳药科大学,辽宁 沈阳 110016, bio={"content":"

赵文鹏(2003—),男,2021级本科生。E-mail:

"}, bioImg=null, bioContent=

赵文鹏(2003—),男,2021级本科生。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233671707111996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, xref=null, ext=[AuthorCompanyExt(id=1330233671715500605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, companyId=1330233671707111996, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016), AuthorCompanyExt(id=1330233671728083518, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, companyId=1330233671707111996, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,辽宁 沈阳 110016)])])], keywords=[Keyword(id=1330233672004907588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=EN, orderNo=1, keyword=antibody-drug conjugate), Keyword(id=1330233672063627845, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=EN, orderNo=2, keyword=monoclonal antibody), Keyword(id=1330233672113959494, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=EN, orderNo=3, keyword=small molecule substance), Keyword(id=1330233672197845575, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=EN, orderNo=4, keyword=formulation development), Keyword(id=1330233672269148744, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=EN, orderNo=5, keyword=stability), Keyword(id=1330233672323674697, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=CN, orderNo=1, keyword=抗体偶联药物), Keyword(id=1330233672382394954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=CN, orderNo=2, keyword=单克隆抗体), Keyword(id=1330233672436920907, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=CN, orderNo=3, keyword=小分子物质), Keyword(id=1330233672504029772, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=CN, orderNo=4, keyword=处方开发), Keyword(id=1330233672554361421, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, language=CN, orderNo=5, keyword=稳定性)], refs=[Reference(id=1330233672675996238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=TSUCHIKAMA N, AN N.Antibody-drug conjugates: recent advances in conjugation and linker chemistries [J].Protein Cell, 2018, 9(1): 33-46., articleTitle=null, refAbstract=null), Reference(id=1330233672734716495, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=刘文超,李鸿峰,胡朝红.抗体偶联药物的技术现状和展望[J].生物化学与生物物理进展,2023,50(5):1167-1189., articleTitle=null, refAbstract=null), Reference(id=1330233672789242448, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=JHAVERI K, HAN H, DOTAN E, et al.460MO Preliminary results from a phase Ⅰ study using the bispecific, human epidermal growth factor 2(HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers [J].Ann Oncol, 2022, 33: S749-S750., articleTitle=null, refAbstract=null), Reference(id=1330233672864739921, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=OH S Y, LEE Y W, LEE E J, et al.Preclinical study of a biparatopic METxMET antibody-drug conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC [J].Clin Cancer Res, 2023, 29(1): 221-232., articleTitle=null, refAbstract=null), Reference(id=1330233672931848786, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=YU J F, FANG T, YUN C Y, et al.Antibody-drug conjugates targeting the human epidermal growth factor receptor family in cancers [J].Front Mol Biosci, 2022, 9: 847835., articleTitle=null, refAbstract=null), Reference(id=1330233672986374739, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LIM J, SARI-AK D, BAGGA T.Siglecs as therapeutic targets in cancer [J].Biology (Basel), 2021, 10(11): 1178., articleTitle=null, refAbstract=null), Reference(id=1330233673057677908, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=MCCOMBS J R, OWEN S C.Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry [J].AAPS J, 2015, 17(2): 339-351., articleTitle=null, refAbstract=null), Reference(id=1330233673124786773, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=浙江新码生物医药有限公司.一种含有抗HER2-药物偶联物的冻干组合物、冻干制剂及其制备方法和用途:中国,113521018A [P].2021-10-22., articleTitle=null, refAbstract=null), Reference(id=1330233673187701334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=DEAN A Q, LUO S, TWOMEY J D, et al.Targeting cancer with antibody-drug conjugates: promises and challenges[J].MABs, 2021, 13(1): 1951427., articleTitle=null, refAbstract=null), Reference(id=1330233673246421591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=GOMES-DA-SILVA L C, KEPP O, KROEMER G.Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death [J].Oncoimmunology, 2020, 9(1): 1841393., articleTitle=null, refAbstract=null), Reference(id=1330233673326113368, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=DUERR C, FRIESS W.Antibody-drug conjugates-stability and formulation [J].Eur J Pharm Biopharm, 2019, 139: 168-176., articleTitle=null, refAbstract=null), Reference(id=1330233673464525401, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=BAROK M, JOENSUU H, ISOLA J.Trastuzumab emtansine: mechanisms of action and drug resistance [J].Breast Cancer Res, 2014, 16(2): 209., articleTitle=null, refAbstract=null), Reference(id=1330233673540022874, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ELGERSMA R C, COUMANS R G E, HUIJBREGTS T, et al.Design, synthesis, and evaluation of linker-duo carmycin payloads: toward selection of HER2-targeting antibody-drug conjugate SYD985 [J].Mol Pharm, 2015, 12(6): 1813-1835., articleTitle=null, refAbstract=null), Reference(id=1330233673598743131, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=KUMAR R, GEORGE B, CAMPBELL M R, et al.HER family in cancer progression: from discovery to 2020 and beyond [J].Adv Cancer Res, 2020, 147: 109-160., articleTitle=null, refAbstract=null), Reference(id=1330233673661657692, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=LONDON M, GALLO E.Epidermal growth factor receptor (EGFR) involvement in epithelial‐derived cancers and its current antibody‐based immunotherapies [J].Cell Biol Int, 2020, 44(6): 1267-1282., articleTitle=null, refAbstract=null), Reference(id=1330233673787486813, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=JOUBERT N, BECK A, DUMONTET C, et al.Antibody-drug conjugates: the last decade [J].Pharmaceuticals, 2020, 13(9): 245., articleTitle=null, refAbstract=null), Reference(id=1330233673858789982, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=根马布股份公司.抗体-药物缀合物冻干制剂:中国,106163567B [P].2021-06-11., articleTitle=null, refAbstract=null), Reference(id=1330233673930093151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=TONG J T W, HARRIS P W R, BRIMBLE M A, et al.An insight into FDA approved antibody-drug conjugates for cancer therapy [J].Molecules, 2021, 26(19): 5847., articleTitle=null, refAbstract=null), Reference(id=1330233674030756448, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=田烨,吴明媛.生物制品冻干保护方法研究进展[J].中国医药生物技术,2018,13(1):73-76., articleTitle=null, refAbstract=null), Reference(id=1330233674093671009, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=KHONGORZUL P, LING C J, KHAN F U, et al.Antibody-drug conjugates: a comprehensive review [J].Mol Cancer Res, 2020, 18(1): 3-19., articleTitle=null, refAbstract=null), Reference(id=1330233674152391266, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=DAN N, SETUA S, KASHYAP V K, et al.Antibody-drug conjugates for cancer therapy: chemistry to clinical implications [J].Pharmaceuticals (Basel), 2018, 11(2): 32., articleTitle=null, refAbstract=null), Reference(id=1330233674202722915, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=PACE A L, WONG R L, ZHANG Y T, et al.Asparagine deamidation dependence on buffer type, pH, and temperature[J].J Pharm Sci, 2013, 102(6): 1712-1723., articleTitle=null, refAbstract=null), Reference(id=1330233674294997604, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=BECKLEY N S, LAZZARESCHI K P, CHIH H W, et al.Investigation into temperature-induced aggregation of an antibody drug conjugate [J].Bioconjug Chem, 2013, 24(10): 1674-1683., articleTitle=null, refAbstract=null), Reference(id=1330233674370495077, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=艾更斯司股份有限公司,西进公司.包含抗191P4D12抗体药物偶联物的药物组合物及其使用方法:中国,113677364A [P].2021-11-19., articleTitle=null, refAbstract=null), Reference(id=1330233674429215334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=霍夫曼-拉罗奇有限公司.皮下抗HER2抗体配制剂:中国,115089704A [P].2022-09-23., articleTitle=null, refAbstract=null), Reference(id=1330233674487935591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MOQUIST P N, BOVEE T D, WAIGHT A B, et al.Novel auristatins with high bystander and cytotoxic activities in drug efflux-positive tumor models [J].Mol Cancer Ther, 2021, 20(2): 320-328., articleTitle=null, refAbstract=null), Reference(id=1330233674559238760, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=ADEM Y T, SCHWARZ K A, DUENAS E, et al.Auristatin antibody drug conjugate physical instability and the role of drug payload [J].Bioconjug Chem, 2014, 25(4): 656-664., articleTitle=null, refAbstract=null), Reference(id=1330233674630541929, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH S K, LUISI D L, PAK R H.Antibody-drug conjugates: design, formulation and physicochemical stability[J].Pharm Res, 2015, 32(11): 3541-3571., articleTitle=null, refAbstract=null), Reference(id=1330233674697650794, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=ZUO P Y.Capturing the magic bullet: pharmacokinetic principles and modeling of antibody-drug conjugates[J].AAPS J, 2020, 22(5): 105., articleTitle=null, refAbstract=null), Reference(id=1330233674760565355, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=ADEM Y T, SCHWARZ K A, DUENAS E, et al.Auristatin antibody drug conjugate physical instability and the role of drug payload [J].Bioconjug Chem, 2014, 25(4): 656-664., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233671707111996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, xref=null, ext=[AuthorCompanyExt(id=1330233671715500605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, companyId=1330233671707111996, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016), AuthorCompanyExt(id=1330233671728083518, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, companyId=1330233671707111996, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,辽宁 沈阳 110016)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.02.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.02.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.02.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1707494400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
ADC的制剂处方设计和优化
赵文鹏
中国医药工业杂志 | 综述 2024,55(2): 176-186
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (2) : 176 -186
ADC的制剂处方设计和优化
全屏
[Author(id=1330233671790998080, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=1192556601@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233671858106946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, authorId=1330233671790998080, language=EN, stringName=Wenpeng ZHAO, firstName=Wenpeng, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shenyang Pharmaceutical University, Shenyang 110016, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233671929410115, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, authorId=1330233671790998080, language=CN, stringName=赵文鹏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=沈阳药科大学,辽宁 沈阳 110016, bio={"content":"

赵文鹏(2003—),男,2021级本科生。E-mail:

"}, bioImg=null, bioContent=

赵文鹏(2003—),男,2021级本科生。E-mail:

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233671707111996, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, xref=null, ext=[AuthorCompanyExt(id=1330233671715500605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, companyId=1330233671707111996, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shenyang Pharmaceutical University, Shenyang 110016), AuthorCompanyExt(id=1330233671728083518, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233671157658169, companyId=1330233671707111996, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=沈阳药科大学,辽宁 沈阳 110016)])])]
赵文鹏
作者信息
  • 沈阳药科大学,辽宁 沈阳 110016
作者简介:

赵文鹏(2003—),男,2021级本科生。E-mail:

Formulation Design and Optimization of ADC
Wenpeng ZHAO
Affiliations
  • Shenyang Pharmaceutical University, Shenyang 110016
出版时间: 2024-02-10 doi: 10.16522/j.cnki.cjph.2024.02.002
文章导航
收藏切换

抗体偶联药物(antibody-drug conjugate,ADC)结合了单克隆抗体的靶向性和小分子物质的强大杀伤力,成为当前生物制药领域的研究焦点。虽然全球已有多种ADC上市,但在配方和稳定性方面仍存在挑战。该文从ADC的抗体、连接子和小分子物质选择的角度,概述了ADC配方开发和临床应用中的关键和难点,并提出了ADC使用期间的稳定性研究方案,旨在为未来ADC的开发提供参考。

抗体偶联药物  /  单克隆抗体  /  小分子物质  /  处方开发  /  稳定性

Antibody-drug conjugates (ADC) combine the targeting ability of monoclonal antibodies and the potent cytotoxicity of small molecule substances, becoming a research focus in the current biopharmaceutical field. Although various ADCs have been marketed globally, challenges still exist in formulation and stability. This review outlines the key points and difficulties in ADC formulation development and clinical application from the perspectives of antibody, linker, and small molecule substance selection for ADC, and proposes a stability study plan during ADC use, aiming to provide references for the future ADC development.

antibody-drug conjugate  /  monoclonal antibody  /  small molecule substance  /  formulation development  /  stability
赵文鹏. ADC的制剂处方设计和优化. 中国医药工业杂志, 2024 , 55 (2) : 176 -186 . DOI: 10.16522/j.cnki.cjph.2024.02.002
Wenpeng ZHAO. Formulation Design and Optimization of ADC[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (2) : 176 -186 . DOI: 10.16522/j.cnki.cjph.2024.02.002

参考文献 引证文献
排序方式:
[1]
TSUCHIKAMA N, AN N.Antibody-drug conjugates: recent advances in conjugation and linker chemistries [J].Protein Cell, 2018, 9(1): 33-46.
[2]
刘文超,李鸿峰,胡朝红.抗体偶联药物的技术现状和展望[J].生物化学与生物物理进展,2023,50(5):1167-1189.
[3]
JHAVERI K, HAN H, DOTAN E, et al.460MO Preliminary results from a phase Ⅰ study using the bispecific, human epidermal growth factor 2(HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers [J].Ann Oncol, 2022, 33: S749-S750.
[4]
OH S Y, LEE Y W, LEE E J, et al.Preclinical study of a biparatopic METxMET antibody-drug conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC [J].Clin Cancer Res, 2023, 29(1): 221-232.
[5]
YU J F, FANG T, YUN C Y, et al.Antibody-drug conjugates targeting the human epidermal growth factor receptor family in cancers [J].Front Mol Biosci, 2022, 9: 847835.
[6]
LIM J, SARI-AK D, BAGGA T.Siglecs as therapeutic targets in cancer [J].Biology (Basel), 2021, 10(11): 1178.
[7]
MCCOMBS J R, OWEN S C.Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry [J].AAPS J, 2015, 17(2): 339-351.
[8]
浙江新码生物医药有限公司.一种含有抗HER2-药物偶联物的冻干组合物、冻干制剂及其制备方法和用途:中国,113521018A [P].2021-10-22.
[9]
DEAN A Q, LUO S, TWOMEY J D, et al.Targeting cancer with antibody-drug conjugates: promises and challenges[J].MABs, 2021, 13(1): 1951427.
[10]
GOMES-DA-SILVA L C, KEPP O, KROEMER G.Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death [J].Oncoimmunology, 2020, 9(1): 1841393.
[11]
DUERR C, FRIESS W.Antibody-drug conjugates-stability and formulation [J].Eur J Pharm Biopharm, 2019, 139: 168-176.
[12]
BAROK M, JOENSUU H, ISOLA J.Trastuzumab emtansine: mechanisms of action and drug resistance [J].Breast Cancer Res, 2014, 16(2): 209.
[13]
ELGERSMA R C, COUMANS R G E, HUIJBREGTS T, et al.Design, synthesis, and evaluation of linker-duo carmycin payloads: toward selection of HER2-targeting antibody-drug conjugate SYD985 [J].Mol Pharm, 2015, 12(6): 1813-1835.
[14]
KUMAR R, GEORGE B, CAMPBELL M R, et al.HER family in cancer progression: from discovery to 2020 and beyond [J].Adv Cancer Res, 2020, 147: 109-160.
[15]
LONDON M, GALLO E.Epidermal growth factor receptor (EGFR) involvement in epithelial‐derived cancers and its current antibody‐based immunotherapies [J].Cell Biol Int, 2020, 44(6): 1267-1282.
[16]
JOUBERT N, BECK A, DUMONTET C, et al.Antibody-drug conjugates: the last decade [J].Pharmaceuticals, 2020, 13(9): 245.
[17]
根马布股份公司.抗体-药物缀合物冻干制剂:中国,106163567B [P].2021-06-11.
[18]
TONG J T W, HARRIS P W R, BRIMBLE M A, et al.An insight into FDA approved antibody-drug conjugates for cancer therapy [J].Molecules, 2021, 26(19): 5847.
[19]
田烨,吴明媛.生物制品冻干保护方法研究进展[J].中国医药生物技术,2018,13(1):73-76.
[20]
KHONGORZUL P, LING C J, KHAN F U, et al.Antibody-drug conjugates: a comprehensive review [J].Mol Cancer Res, 2020, 18(1): 3-19.
[21]
DAN N, SETUA S, KASHYAP V K, et al.Antibody-drug conjugates for cancer therapy: chemistry to clinical implications [J].Pharmaceuticals (Basel), 2018, 11(2): 32.
[22]
PACE A L, WONG R L, ZHANG Y T, et al.Asparagine deamidation dependence on buffer type, pH, and temperature[J].J Pharm Sci, 2013, 102(6): 1712-1723.
[23]
BECKLEY N S, LAZZARESCHI K P, CHIH H W, et al.Investigation into temperature-induced aggregation of an antibody drug conjugate [J].Bioconjug Chem, 2013, 24(10): 1674-1683.
[24]
艾更斯司股份有限公司,西进公司.包含抗191P4D12抗体药物偶联物的药物组合物及其使用方法:中国,113677364A [P].2021-11-19.
[25]
霍夫曼-拉罗奇有限公司.皮下抗HER2抗体配制剂:中国,115089704A [P].2022-09-23.
[26]
MOQUIST P N, BOVEE T D, WAIGHT A B, et al.Novel auristatins with high bystander and cytotoxic activities in drug efflux-positive tumor models [J].Mol Cancer Ther, 2021, 20(2): 320-328.
[27]
ADEM Y T, SCHWARZ K A, DUENAS E, et al.Auristatin antibody drug conjugate physical instability and the role of drug payload [J].Bioconjug Chem, 2014, 25(4): 656-664.
[28]
SINGH S K, LUISI D L, PAK R H.Antibody-drug conjugates: design, formulation and physicochemical stability[J].Pharm Res, 2015, 32(11): 3541-3571.
[29]
ZUO P Y.Capturing the magic bullet: pharmacokinetic principles and modeling of antibody-drug conjugates[J].AAPS J, 2020, 22(5): 105.
[30]
ADEM Y T, SCHWARZ K A, DUENAS E, et al.Auristatin antibody drug conjugate physical instability and the role of drug payload [J].Bioconjug Chem, 2014, 25(4): 656-664.
2024年第55卷第2期
27
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.02.002
  • 接收时间:2023-09-04
  • 首发时间:2026-11-19
  • 出版时间:2024-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-09-04
基金
作者信息
    沈阳药科大学,辽宁 沈阳 110016
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏